|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Collaboration agreement revenue | |||||
| Product | |||||
| Collaboration Agreement | |||||
| Total collaboration agreement revenue | |||||
| Costs and expenses: | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Total costs and expenses | |||||
| Operating loss | |||||
| Other income (expense): | |||||
| Total other income, net | |||||
| Net loss | |||||
| Net loss per share, basic and diluted (in dollars per share) | |||||
| Weighted-average shares used in computing net loss per share, basic and diluted (in shares) | |||||
Loading...